Activity of Plant Extracts Used in Northern Nigerian Traditional Medicine Against Methicillin-Resistant
Activity of Plant Extracts Used in Northern Nigerian Traditional Medicine Against Methicillin-Resistant
Activity of Plant Extracts Used in Northern Nigerian Traditional Medicine Against Methicillin-Resistant
1– 8
1
Aliyu et al., Nig. Journ. Pharm. Sci., March, 2008, Vol. 7 No. 1, P. 1– 8
2006). Hospital surveillance data in 2001 has attention of phytochemists across the globe
shown that MRSA was the biggest threat in (Polombo and Semple, 2002;
China, where resistance among hospital- Voravuthikunchai and Kitpipit, 2005; Aqil, et
acquired infections reaches almost 90% al., 2006). In this study, we report the
(Zhang et al., 2006). In Nigeria, Kenya and screening of twelve (12) medicinal plants used
Cameroon, the rate of MRSA spread was in Northern Nigerian traditional medicine,
about 21-30% in 2003 (Kesah et al., 2003), against methicillin resistance Staphylococcus
however, prevalence rate of about 69% of aureus (MRSA).
MRSA isolates was obtained in a study among
healthy women in Zaria, Nigeria (Onanuga , et MATERIALS AND METHODS
al., 2005). The problem of microbial Plant materials
resistance to antibiotics is fast growing The twelve (12) medicinal plants were
particularly in the hospitals where methicillin- collected between February, 2006 and
resistant Staphylococcus aureus has become a September, 2007 at Dakace village in Zaria,
global threat to antimicrobial chemotherapy. Kaduna state, Rogo village in Kano state,
This situation seems to pose the outlook for Tsafe in Zamfara State and Funtua in Katsina
the use of antimicrobial drugs in future to be state, Northern Nigeria. The plants were
uncertain (Nascimento, et al., 2000); as a authenticated at the Herbarium unit,
result, the search for new ways to treat MRSA Department of Biological Sciences, Ahmadu
infections stimulates research into natural Bello University, Zaria. Voucher specimens
products from medicinal plants. In Northern were deposited there for future reference.
Nigerian traditional medicine, many Samples were air dried for two weeks and
indigenous plant are widely used in the pulverized to powder form using mortar and
treatment of various infectious diseases; such pestle.
plants includes Acacia albida, Anchomanes Preparation of extracts
difformis, Boscia senegalensis, Bridelia Fifty gramme of powdered sample of each
ferruginea, Ficus ingens, Indigofera arrecta, plant was extracted exhaustively (cold
Moringa oleifera, Mormodica basalmina, maceration) with methanol (and ethanol only
Pavetta crassipes, Phyllanthus amarus and on Moringa oleifera and Vernonia
Vernonia bluemoides. Many of these plants blumeoides) for 48 h. The extracts were
have records of widespread claims of filtered using Whatman filter paper no. 2, and
therapeutic effectiveness against infectious concentrated at reduced pressure to afford the
and non infectious diseases across Northern various crude extracts of the twelve plants
Nigeria, West Africa and beyond (Burkill, samples. The samples were kept in the
1995). Plants extracts or their active principles refrigerator at 5°C before use.
have enormous therapeutic potentials (Iwu et Phytochemical screening
al., 1999) and the continued investigation of The extract was subjected to various
their secondary metabolites has led to phytochemical tests to identify the chemical
important breakthrough in pharmacology and constituent present using standard methods as
has helped tremendously in the development described by Sofowora (1993) and Trease and
of modern pharmacotherapeutics in Africa and Evans (1989).
other part of the world (Doerge, et al., 1971; Bacterial culture
Nwaogu, et al., 2007). In recent times, The MRSA strains used in this study were
research interest for active chemical agents clinical isolates from urethral swab, seminal
against MRSA, especially from indigenous fluid, urine, high virginal swab, blood, skin
medicinal plants resources has received the and sputum of patients presenting with
2
Aliyu et al., Nig. Journ. Pharm. Sci., March, 2008, Vol. 7 No. 1, P. 1– 8
3
Aliyu et al., Nig. Journ. Pharm. Sci., March, 2008, Vol. 7 No. 1, P. 1– 8
4
Aliyu et al., Nig. Journ. Pharm. Sci., March, 2008, Vol. 7 No. 1, P. 1– 8
5
Aliyu et al., Nig. Journ. Pharm. Sci., March, 2008, Vol. 7 No. 1, P. 1– 8
REFERENCES
Abu-Shanab, B., Adwan, G., Jarrar, N., Abu-hijleh, A., Akinyemi, K.O., Oladipo, O., Okwara, C.E., Ibe, C. C.,
Adwan, K. (2006). Antibacterial activity of four plants Fasure, A.A. (2005). Screening of crude extracts of six
extracts used in Palestine in folk medicine against medicinal plants used in South-Western Nigerian
Methicillin-Resistant Staphylococcus aureus. Turk. J. unorthodox medicine for anti-methicillin resistant
Biol., (30), 195-198. Staphylococcus aureus activity. BMC. Comp. Altern.
Med., 5:6
6
Aliyu et al., Nig. Journ. Pharm. Sci., March, 2008, Vol. 7 No. 1, P. 1– 8
7
Aliyu et al., Nig. Journ. Pharm. Sci., March, 2008, Vol. 7 No. 1, P. 1– 8
Polombo, E.A., Semple, S.J. (2002). Antibacterial Antimicrobial activity of Bridelia ferruginea leaves
activity of Australian plants extracts against extracts. Fitoter. 73(4),343-345.
methicillin-resistant Staphylococcus aureus (MRSA)
and vancomycin-reisitant enterococci (VRE). J. Bas. Trease, G.E. and Evans, W.C. (1989). Pharmacognosy,
Microbio.l 42(6),444-448. 13th edition; ELBS Oxford University Press, London,
UK, Pp. 245-263.
Rios, J.L., Recio, M.C. (2005). Medicinal plants and
antimicrobial activity. J. Ethnopharmacol. 100, 80-81. Voravuthikunchai, S.P., Kitpipit, L. (2005). Activity of
medicinal plant extracts against hospital isolates of
Sofowora, A. (1993). Medicinal Plants and Traditional methicillin resistant Staphylococcus aureus. Clin.
Medicine in Africa. 2nd edition; Spectrum Books Ltd, Microbiol. Infect. 11(6), 510-512.
Ibadan, Nigeria. p. 289.
Zhang, R., Eggleston, K., Rotimi, V., Zeckhauser, R.J.
Talla, E., Djamen, D., Djouldé, D., Tatsadjeu, L., (2006). Antibiotic resistance as a global threat:
Tantoh, D., Mbafor, J.T., Fomum, Z.T. (2002). Evidence from China, Kuwait and the United States.
Globalization and Health 2(6), 1-14.